PEOPLE - Focal (US) makes appointment:
This article was originally published in Clinica
Executive Summary
US surgical sealant company Focal has appointed Robert DePasqua president, CEO and member of the board. Mr DePasqua, a former CEO of Biolink and Spectranetics, replaces interim president and CEO, Donald Grilli, who takes on the new role of chairman. Focal's previous president and CEO, David Clapper, resigned late last year due to a chronic family medical condition.